There are currently 322 clinical trials in Fort Worth, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including Cook Children's Medical Center, GSK Investigational Site, Cook Children's Medical Center - Fort Worth and UT Southwestern/Simmons Cancer Center-Fort Worth. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
NCT03489629
Recruiting
To evaluate the micro-biologic efficacy and safety of a streamlined treatment for early onset methicillin-resistant staphylococcus aureus (MRSA) in patients with cystic fibrosis.
Gender:
All
Ages:
Between 2 years and 45 years
Trial Updated:
04/08/2024
Locations: Cook Children's Medical Center, Fort Worth, Texas
Conditions: Cystic Fibrosis
Register for Updates
Promoting Recovery Outcomes Through Precise Early Locomotor Interventions in Persons With Spinal Cord Injury
NCT06176833
Recruiting
The purpose of this study is to evaluate if a specific type of additional walking therapy, called body weight supported treadmill training (BWSTT) affects walking ability following a traumatic spinal cord injury. Specifically, the study will look at whether starting BWSTT, which uses a body harness to support body weight while walking on a treadmill at different times within the first 6 months after the injury, makes a difference in how effective this therapy may be, While we know that the brain... Read More
Gender:
All
Ages:
Between 16 years and 75 years
Trial Updated:
04/04/2024
Locations: Baylor Scott and White Institute for Rehabilitation, Fort Worth, Texas
Conditions: Spinal Cord Injuries
Register for Updates
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
NCT06322693
Recruiting
This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022. The study will be conducted in 2 parts with Part 1 consisting of dose escalation and Part 2 dose expansion. Part 1 will determine the recommended Phase 2 dose (RP2D) of TSR-022 and Part 2 will evaluate the antitumor activity of TSR-022 in combination with TSR-042 or docetaxel and as monotherapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/14/2024
Locations: GSK Investigational Site, Fort Worth, Texas
Conditions: Neoplasms
Register for Updates
PRECISION Pain Research Registry
NCT04853732
Recruiting
The PRECISION Pain Research Registry enrolls participants with chronic low back pain (cases) and participants who are free of chronic pain (controls) to study the epidemiology and management of chronic pain. The vision of the registry is to conduct research to provide a future for all unbounded by pain.
Gender:
All
Ages:
Between 21 years and 79 years
Trial Updated:
01/11/2024
Locations: University of North Texas Health Science Center, Fort Worth, Texas
Conditions: Chronic Low Back Pain
Register for Updates
C-Brace Prospective Registry
NCT04640584
Recruiting
To gather prospective safety and effectiveness data for the C-Brace System following the standard of care.
Gender:
All
Ages:
All
Trial Updated:
01/09/2024
Locations: Baker O&P, Fort Worth, Texas
Conditions: Pareses, Lower Extremity
Register for Updates
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
NCT05706181
Recruiting
To test the hypothesis that home-based leg heat therapy improves functional capacity, vascular function, and exercise hyperemia in older adults.
Gender:
All
Ages:
Between 55 years and 80 years
Trial Updated:
12/06/2023
Locations: University of North Texas Health Science Center, Fort Worth, Texas
Conditions: Aging Well, Walking, Difficulty, Hyperemia
Register for Updates
Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
NCT05705505
Recruiting
This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.
Gender:
Female
Ages:
18 years and above
Trial Updated:
12/05/2023
Locations: Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas
Conditions: Endometrioid Endometrial Cancer
Register for Updates
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
NCT04951219
Recruiting
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Texas Digestive Disease Consultants, Fort Worth, Texas
Conditions: Non-Alcoholic Fatty Liver Disease
Register for Updates
The Pediatric Anesthesia Quality Improvement Project
NCT00674388
Recruiting
The Study is designed to collect information about adverse events that occur in children undergoing anesthesia in participating hospitals. Demographic information will be collected on all anesthetics. An analysis of each adverse event will be performed and entered into the database. From this information we will devise strategies to prevent these adverse events.
Gender:
All
Ages:
21 years and below
Trial Updated:
11/20/2023
Locations: Cook Children's Health Care System, Fort Worth, Texas
Conditions: Surgery, Anesthesia, Children
Register for Updates
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
NCT05082519
Recruiting
This study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL). Higher amounts of body fat is associated with resistance to chemotherapy in patients with B-ALL. Chemotherapy during the first month causes large gains in body fat in most people, even those who start chemotherapy at a healthy weight. This study is being done to find out if caloric restriction achieved by a personalized nutritional menu and exercise plan during routine chemotherapy... Read More
Gender:
All
Ages:
Between 10 years and 25 years
Trial Updated:
10/25/2023
Locations: Cook Children's Medical Center, Fort Worth, Texas
Conditions: B-cell Acute Lymphoblastic Leukemia, Obesity
Register for Updates
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971
Recruiting
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/17/2023
Locations: Dallas Fort Worth Clinical Research Associates, Fort Worth, Texas
Conditions: Gout, Hyperuricemia, Gout Flare, Tophi
Register for Updates
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
NCT05875948
Recruiting
This study aims to evaluate the safety, tolerability and efficacy of R2R01 combined with terlipressin as compared to terlipressin alone in the treatment of patients with HRS-AKI
Gender:
All
Ages:
18 years and above
Trial Updated:
09/29/2023
Locations: Baylor Scott and White All Saints Medical Center, Fort Worth, Texas
Conditions: Hepatorenal Syndrome, Acute Kidney Injury
Register for Updates